Sharing Alzheimer’s biomarker results with older adults living in the community
Returning AD biomarker Results to Community Dwelling Older Adults: Testing Modalities and Impact
This project tries different ways to give people aged 65 and older clear and safe information about Alzheimer’s biomarker test results.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11171530 on NIH RePORTER |
What this research studies
You would be asked about how you want to receive results from tests that look for early Alzheimer’s brain changes, including newer blood tests. Researchers will develop and try different methods for giving results directly to participants—using plain language, counseling support, and follow-up—to see what is safe and understandable. The project focuses on older adults living in the community and will track emotional, behavioral, and healthcare effects after results are returned. Results will inform how clinicians and labs should share biomarker results now that blood tests and new treatments are changing care.
Who could benefit from this research
Good fit: Ideal candidates are community-dwelling adults aged 65 or older who have had or may have Alzheimer’s biomarker testing and are willing to receive results.
Not a fit: People with moderate to severe dementia, those who do not want to learn biomarker results, or those living outside the study’s recruitment area may not benefit.
Why it matters
Potential benefit: If successful, this could help older adults understand their Alzheimer’s risk earlier and make informed care and planning choices.
How similar studies have performed: Previous research has safely returned Alzheimer’s biomarker results in specialty settings, but returning blood-based preclinical results directly to community-dwelling older adults is a newer approach.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: Mozersky, Jessica — Washington University
- Study coordinator: Mozersky, Jessica
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.